When did Heliogen go public?
Heliogen, Inc., a renewable energy technology company specializing in concentrated solar power systems utilizing artificial intelligence, officially completed its initial public offering and began trading its shares on the New York Stock Exchange under the ticker symbol HLGN on December 31, 2021. The public market debut was achieved through a business combination with a special purpose acquisition company, raising vital capital to scale its innovative clean energy hardware.
Related FAQs
Elon Musk's most prominent new stock is the recently listed SpaceX, which trades under the ticker symbol SPCX. Following its June 2026 IPO, it became a major fixture on the NASDAQ exchange.
Axogen, Inc. (traded on the Nasdaq under the ticker symbol AXGN) is a medical technology enterprise dedicated to the development and commercialization of proprietary surgical solutions for peripheral nerve repair and regeneration.
Market analysts covering AxoGen generally evaluate the medical technology stock with a balanced perspective, often leaning toward a cautious buy or hold rating.
Heliogen, Inc. trades on the New York Stock Exchange under the official stock ticker symbol HLGN.
AxoGen has historically operated as a growth-stage medical device company focused heavily on scaling its commercial infrastructure, clinical education programs, and product manufacturing capacity, which has often resulted in net losses.
Heliogen, Inc. trades under the ticker symbol HLGN at a live market price of approximately $1.70 per share.
Space Exploration Technologies Corp., widely known as SpaceX, operates entirely as a privately held aerospace manufacturer and satellite communication enterprise founded by Elon Musk.
As of July 2026, Heliogen’s trailing twelve-month (TTM) revenue is reported at approximately ₹1.75 billion.
Heliogen, Inc. is a renewable energy technology enterprise that specializes in developing advanced concentrated solar power systems designed to decarbonize heavy industrial manufacturing.